Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -144,165 | -92,344 | -39,572 | -112,961 | -79,006 |
| Depreciation Amortization | -15,126 | -10,775 | -5,232 | -7,545 | -4,693 |
| Accounts receivable | N/A | N/A | N/A | 193 | -6,492 |
| Accounts payable and accrued liabilities | 5,304 | 9,243 | -453 | 2,635 | 890 |
| Other Working Capital | 8,101 | 10,378 | -5,321 | -13,207 | -21,468 |
| Other Operating Activity | 19,957 | 6,803 | 6,765 | 15,661 | 19,293 |
| Operating Cash Flow | $-125,929 | $-76,695 | $-43,813 | $-115,224 | $-91,476 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -302,695 | -283,116 | -352,646 | -156,088 | -44,983 |
| PPE Investments | -2,755 | -2,298 | -1,325 | -2,368 | -1,530 |
| Investing Cash Flow | $-305,450 | $-285,414 | $-353,971 | $-158,456 | $-46,513 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 674,017 | 387,513 | 349,111 | 361,504 | 221,186 |
| Other Financing Activity | 781 | 781 | 0 | 1,213 | 637 |
| Financing Cash Flow | $674,798 | $388,294 | $349,111 | $362,717 | $221,823 |
| Beginning Cash Position | 157,775 | 157,775 | 157,775 | 68,738 | 68,738 |
| End Cash Position | 401,194 | 183,960 | 109,102 | 157,775 | 152,572 |
| Net Cash Flow | $243,419 | $26,185 | $-48,673 | $89,037 | $83,834 |
| Free Cash Flow | |||||
| Operating Cash Flow | -125,929 | -76,695 | -43,813 | -115,224 | -91,476 |
| Capital Expenditure | -2,755 | -2,298 | -1,325 | -2,368 | -1,530 |
| Free Cash Flow | -128,684 | -78,993 | -45,138 | -117,592 | -93,006 |